Corporate News
FONT-SIZE Plus   Neg

Pre-market Movers For Dec 17 (AAPL, S, CLWR, ENZN, LXRX, HW, TZYM)

Trade AAPL now with 


Apple Inc. (AAPL: Quote) is rising 0.53 percent to $512.48. The company announced that it sold over two million of its new iPhone 5 in China, after its launch on December 14. iPhone 5 will be available in more than 100 countries by the end of the month.

Enzon Pharmaceuticals Inc. (ENZN: Quote) is rising 11 percent to $5.08. The company announced a review of the possible sale or disposition of one or more corporate assets, or a sale of the company. Based on clinical data on the androgen receptor program, the company plans to suspend clinical development with a goal to conserve capital and maximize value returned to shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX: Quote) is up 10 percent to $2.06 based on the news that it has received a Fast Track status from the FDA for the development of LX1033.


Headwaters Inc. (HW: Quote) is down nearly 4 percent to $7.02. The company announced a public offering of 7.6 million shares of its common stock.

Clearwire Corp. (CLWR: Quote) is down 9 percent to $3.07. Sprint Nextel Corp. (S) has entered into a definitive agreement to acquire approximately 50 percent stake in Clearwire it does not currently own for $2.97 per share. Last week, Sprint offered to buy Clearwire shares at $2.90 per share. S is up nearly 2 percent to $5.65.

Trading halt:

Trading in shares of Tranzyme Pharma (TZYM: Quote) was halted. The company announced that it is discontinuing and immediately ending patient enrollment in DIGEST, a Phase 2b trial in diabetic patients receiving TZP-102 for the management of symptoms of gastroparesis, due to insufficient efficacy.

To receive FREE breaking news email alerts for Apple Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback:

Business News

comments powered by Disqus